Results
74,087 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Ninan ShibuChief Accounting Officer |  OKTAOkta, Inc.Option exercise | M | — 836 sh | Sep 17, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Option exercise | M | — 836 sh | Sep 17, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Tax withholding | F | — 1,118 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Option exercise | M | — 2,196 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Gummadi SuryaPresident - Americas |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOption exercise | M | — 598 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Fortunato DavidDirector, CEO and President |  WLTHWEALTHFRONT CORPOption exercise | M | — 76.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Option exercise | M | — 59.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Option exercise | M | — 79.2K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Option exercise | M | — 19.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Jain RohiniChief Financial Officer |  BILLBILL Holdings, Inc.Grant or award | A | — 67.7K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $116K 1,332 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 5 | Cieri MichaelChief Product Officer | BILLBILL Holdings, Inc. Grant or award | A | — 46.9K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Lin LaurenCLO, CCO and Secretary | WLTHWEALTHFRONT CORP Option exercise | M | — 12.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Option exercise | M | — 20.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Vasquez Alison GautEVP AND CFO |  ORNOrion Group Holdings IncGrant or award | A | $15K 2,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Imberman AlanCFO and Treasurer | WLTHWEALTHFRONT CORP Option exercise | M | — 17.8K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Tax withholding | F | — 426 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Ninan ShibuChief Accounting Officer | OKTAOkta, Inc. Option exercise | M | — 1,129 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Tax withholding | F | $48K 914 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Addison Jonathan JamesChief Revenue Officer | OKTAOkta, Inc. Option exercise | M | — 3,591 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Kim John SunshinCLO, CAO & Corporate Secretary | CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP Option exercise | M | — 1,647 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Singisetti Ravi KumarDirector, Chief Executive Officer | CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP Option exercise | M | — 5,987 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Inrig JulaEVP, Head of R&D & CMO |  TVTXTravere Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 32.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Choudary Kiran KumarChief Financial Officer |  RBRKRubrik, Inc.Option exercise · 10b5-1 plan | M | — 4,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $341K 60.0K sh | Sep 17, 2026 traded Sep 17, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $337K 60.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $333K 60.0K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 4 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $382K 75.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 300 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 3 | Kenneweg JohnSVP, Sales & Product Marketing |  MASS908 Devices Inc.Option exercise · 10b5-1 plan | M | $21K 21.4K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,525 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,818 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Tax withholding | F | — 1,386 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Option exercise | M | — 3,520 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Option exercise | M | — 3,873 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $69K 2,500 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Bicket JohnDirector, SEE REMARKS, 10% Owner |  IOTSamsara Inc.Derivative conversion | C | — 305.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 2 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $349K 20.0K sh | Sep 17, 2026 traded Sep 15, 2026 |